Left Atrial Appendage Closure and TAVR – A Matter of Timing and Patient Selection

References

• Nishimura RA , Otto CM , Bonow RO , et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol . 2017;70:252–289. doi:10.1016/j.jacc.2017.03.011.
   PubMed Web of Science ®Google Scholar
• Baumgartner H , Falk V , Bax JJ , et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J . 2017;38:2739–2791. doi:10.1093/eurheartj/ehx391.
   PubMed Web of Science ®Google Scholar
• Tarantini G , Mojoli M , Urena M , Vahanian A. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J . 2017;38:1285–1293. doi:10.1093/eurheartj/ehw456.
   Web of Science ®Google Scholar
• Vranckx P , Windecker S , Welsh RC , Valgimigli M , Mehran R , Dangas G. Thrombo-embolic prevention after transcatheter aortic valve implantation. Eur Heart J . 2017;38:3341–3350. doi:10.1093/eurheartj/ehx390.
   PubMed Web of Science ®Google Scholar
• Genereux P , Cohen DJ , Williams MR , et al. Bleeding complications after surgical aortic valve replacement compared with transcatheter aortic valve replacement: insights from the PARTNER I Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol . 2014;63:1100–1109. doi:10.1016/j.jacc.2013.10.058.
   PubMed Web of Science ®Google Scholar
• Honda YYM , Araki M , Tada N , et al. Impact of HAS-BLED score to predict trans femoral transcatheter aortic valve replacement outcomes. Catheter Cardiovasc Interv . 2018. doi:10.1002/ccd.27596.
   Web of Science ®Google Scholar
• Reddy VY , Doshi SK , Kar S , et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol . 2017;70:2964–2975. doi:10.1016/j.jacc.2017.10.021.
   PubMed Web of Science ®Google Scholar
• Gilhofer TS , Obeid S , Luescher TF , Binder, RK. Simultaneous transcatheter aortic valve implantation and left atrial appendage occlusion versus both interventions as stand-alone procedures. Struct Heart. 2018;2:this issue.
   Google Scholar
• Attinger-Toller A , Maisano F , Senn O , et al. “One-stop shop”: safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion. JACC Cardiovasc Interv . 2016;9:1487–1495. doi:10.1016/j.jcin.2016.04.038.
   PubMed Web of Science ®Google Scholar
• Barbanti M , Webb JG , Gilard M , Capodanno D , Tamburino C . Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention . 2017;13:AA11–AA21. doi:10.4244/EIJ-D-17-00567.
   PubMed Web of Science ®Google Scholar
• Berti S , Pastormerlo LE , Santoro G , et al. Intracardiac versus transesophageal echocardiographic guidance for left atrial appendage occlusion: the LAAO Italian multicenter registry. JACC Cardiovasc Interv . 2018;11:1086–1092. doi:10.1016/j.jcin.2018.05.008.
   PubMed Web of Science ®Google Scholar
• Chakravarty T , Sondergaard L , Friedman J , et al. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet . 2017;389:2383–2392. doi:10.1016/S0140-6736(17)30757-2.
   PubMed Web of Science ®Google Scholar
• Nishimura RA , Otto CM , Bonow RO , et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol . 2014;63:2438–2488. doi:10.1016/j.jacc.2014.02.537.
   PubMed Web of Science ®Google Scholar
• Siontis KC , Yao X , Gersh BJ , Noseworthy PA . Direct oral anticoagulants in patients with atrial fibrillation and valvular heart disease other than significant mitral stenosis and mechanical valves: a meta-analysis. Circulation . 2017;135:714–716. doi:10.1161/CIRCULATIONAHA.116.026793.
   Web of Science ®Google Scholar